CDY 1.43% 7.1¢ cellmid limited

Ann: Preliminary Final Report, page-99

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,750 Posts.
    lightbulb Created with Sketch. 132
    you aint seen nothing yet if you think 12 years is too long. Try hanging on to Pacific Edge for nearly 20 years like some people I know.

    So your theory is that if we get a new CEO the market will think this is great and the share price will rise accordingly.
    Please advise who this contender is if there is one or is it just airy fairy somebody might show up half baked millennial "street smart" conjecture.

    Investment in life sciences companies There are a number of inherent risks associated with the research, development and commercialisation of pharmaceutical products. Investment in companies specialising in these activities carry specific risks which are different to those associated with trading and manufacturing businesses. As such, these companies should be regarded as highly speculative. Cellmid recommends that investors seek professional advice before making an investment in its shares.

    This shows up at the end of every CDY announcement
    So whos your broker?
    Last edited by Pharmargeddon: 01/09/18
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.